Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $0.50 -0.12 (-19.20%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cyclacel Pharmaceuticals Stock Price Performance5 Day Performance-23.14%1 Month Performance-45.70%3 Month Performance-68.83%6 Month Performance-74.75%Year-To-Date Performance-81.09%1 Year Performance-94.21% Receive CYCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… CYCC Stock Chart for Monday, November, 4, 2024 CYCC Chart by TradingView Cyclacel Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$0.63$0.51-19.44%$0.62$0.50659,409 shs$1.09 million11/01/2024$0.65$0.63-3.41%$0.64$0.60214,590 shs$1.35 million10/31/2024$0.66$0.65-1.22%$0.67$0.62201,763 shs$1.40 million10/30/2024$0.68$0.66-3.38%$0.69$0.64612,745 shs$1.41 million10/29/2024$0.70$0.68-2.86%$0.70$0.60495,598 shs$1.46 million10/28/2024$0.83$0.70-15.87%$0.86$0.671.43 million shs$1.51 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$0.87$0.83-4.44%$0.89$0.79761,722 shs$1.79 million10/24/2024$1.06$0.87-17.86%$1.01$0.811.92 million shs$1.87 million10/23/2024$1.43$1.06-25.87%$1.67$1.0111.90 million shs$2.28 million10/22/2024$1.32$1.43+8.33%$2.49$1.3827.41 million shs$3.07 million10/21/2024$1.14$1.32+15.79%$1.44$1.212.42 million shs$2.84 million10/18/2024$1.01$1.14+12.87%$1.99$1.0414.37 million shs$2.45 million10/17/2024$0.99$1.01+2.02%$1.18$0.95930,676 shs$2.17 million10/16/2024$0.86$0.99+15.12%$1.05$0.86198,057 shs$2.13 million10/15/2024$0.82$0.86+4.88%$0.87$0.7930,457 shs$1.85 million10/14/2024$0.80$0.82+2.50%$0.82$0.7919,933 shs$1.76 million10/11/2024$0.80$0.80+0.63%$0.80$0.7719,715 shs$1.58 million10/10/2024$0.77$0.80+3.65%$0.81$0.7523,840 shs$1.16 million10/09/2024$0.89$0.77-13.82%$0.94$0.77134,867 shs$1.12 million10/08/2024$0.95$0.89-6.04%$0.94$0.8832,996 shs$1.30 million10/07/2024$0.91$0.95+3.70%$0.98$0.9118,515 shs$1.39 million10/04/2024$0.91$0.93+1.71%$0.98$0.9013,235 shs$1.36 million10/03/2024$0.96$0.91-4.75%$0.98$0.9120,039 shs$1.34 million10/02/2024$0.96$0.96$0.97$0.9410,012 shs$1.40 million10/01/2024$0.99$0.96-3.03%$1.01$0.9525,084 shs$1.40 million09/30/2024$1.03$0.99-3.88%$1.02$0.9830,771 shs$1.45 million09/27/2024$1.02$1.03+0.98%$1.05$1.0015,875 shs$2.03 million09/26/2024$1.02$1.02$1.08$1.0040,276 shs$2.01 million09/25/2024$1.00$1.02+2.00%$1.13$1.0183,578 shs$2.01 million09/24/2024$1.00$1.00$1.03$0.9913,955 shs$1.46 million09/23/2024$0.98$1.00+2.04%$1.03$0.9945,232 shs$1.46 million09/20/2024$1.03$0.98-4.85%$1.06$0.9848,113 shs$1.93 million09/19/2024$1.05$1.03-1.44%$1.06$1.0020,405 shs$2.03 million09/18/2024$1.07$1.05-2.34%$1.07$1.0033,521 shs$2.06 million09/17/2024$1.07$1.07$1.07$1.0112,057 shs$1.57 million09/16/2024$1.01$1.07+5.94%$1.10$1.0234,022 shs$1.57 million09/13/2024$1.06$1.05-0.94%$1.06$1.0117,093 shs$2.07 million09/12/2024$1.09$1.06-2.75%$1.10$1.0315,567 shs$1.55 million09/11/2024$1.11$1.09-1.80%$1.10$1.0334,720 shs$1.60 million09/10/2024$1.12$1.11-0.89%$1.12$1.055,208 shs$2.19 millionThe Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth09/09/2024$1.06$1.12+5.66%$1.12$1.0740,410 shs$2.21 million09/06/2024$1.05$1.06+0.95%$1.08$1.0322,470 shs$2.09 million09/05/2024$1.06$1.05-0.94%$1.08$1.0326,738 shs$1.54 million09/04/2024$1.08$1.06-1.85%$1.07$1.0412,404 shs$1.55 million09/03/2024$1.05$1.08+2.66%$1.08$1.0233,920 shs$1.58 million09/02/2024$1.05$1.05$1.05$1.0077,700 shs$1.54 million08/30/2024$1.04$1.03-0.96%$1.05$1.0077,750 shs$1.51 million08/29/2024$1.13$1.04-7.96%$1.12$0.9598,266 shs$1.52 million08/28/2024$1.16$1.13-2.59%$1.16$1.0848,700 shs$1.70 million08/27/2024$1.25$1.16-7.20%$1.21$1.1639,907 shs$2.29 million08/26/2024$1.22$1.25+2.47%$1.26$1.1733,230 shs$2.46 million08/23/2024$1.20$1.22+1.67%$1.23$1.1732,906 shs$2.40 million08/22/2024$1.20$1.20$1.23$1.1661,821 shs$2.36 million08/21/2024$1.24$1.20-3.23%$1.24$1.1553,240 shs$2.36 million08/20/2024$1.24$1.24$1.28$1.2231,801 shs$2.44 million08/19/2024$1.27$1.24-2.36%$1.27$1.2159,857 shs$1.81 million08/16/2024$1.32$1.27-3.79%$1.32$1.22153,176 shs$1.85 million08/15/2024$1.45$1.32-8.97%$1.61$1.23607,733 shs$1.93 million08/14/2024$1.38$1.45+5.07%$1.48$1.3196,881 shs$2.12 million08/13/2024$1.37$1.38+0.51%$1.42$1.3426,570 shs$2.02 million08/12/2024$1.42$1.37-3.31%$1.43$1.3527,472 shs$2.01 million08/09/2024$1.45$1.42-2.07%$1.48$1.3753,272 shs$2.07 million08/08/2024$1.49$1.45-2.68%$1.53$1.3831,405 shs$2.12 million08/07/2024$1.46$1.49+2.05%$1.53$1.4716,513 shs$2.18 million08/06/2024$1.46$1.46$1.63$1.4667,968 shs$2.14 million08/05/2024$1.62$1.46-9.88%$1.58$1.3760,230 shs$2.13 million Related Companies Edesa Biotech Stock Chart Avalo Therapeutics Stock Chart Trinity Biotech Stock Chart Vincerx Pharma Stock Chart Addex Therapeutics Stock Chart NKGen Biotech Stock Chart GlycoMimetics Stock Chart RedHill Biopharma Stock Chart PHAXIAM Therapeutics Stock Chart Orgenesis Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
